|
| |
| KLSE: PHARMA (7081) | PHARMANIAGA BHD | MAIN : Health Care |
| Last Price | Today's Change | Day's Range | Trading Volume |
| 5.16 |  -0.01 (0.19%) | 5.05 - 5.18 | 109,300 |
Financials
Market Cap: 1,350 Million
| Latest Audited Result: 31-Dec-2019
| Latest Quarter: 30-Sep-2020 [#3]
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Annual (Unaudited) ( EPS: -57.02, P/E: -9.05 )
| T4Q Result ( EPS: -55.32, P/E: -9.33 )
| Annualized Result ( EPS: 17.23, P/E: 29.95 )
|
Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Click here to modify the Visible Columns.
| Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
| 31-Dec-2020 | 19-Nov-2020 | 30-Sep-2020 | 3 | 624,804 | 4,093 | 1,294 | 1,442 | 3,920 | 345,040 | 271.91% | 0.21% | 0.42% | 261,394 | 239.03 | 238.74 | 0.55 | 0.55 | 1.50 | 1.50 | 1.3200 | 1.32 | -85.55%
| 199.79% | 30-Sep-2020 | 4.32 | 1.81 | 783.09 | 3.27 | 0.13% | 0.35% | 19-Nov-2020 | 5.72 | 2.39 | 1,036.87 | 4.33 | 0.10% | 0.26% |
| 31-Dec-2020 | 19-Aug-2020 | 30-Jun-2020 | 2 | 645,763 | 14,326 | 9,607 | 9,979 | 6,530 | 357,891 | 65.45% | 1.49% | 2.79% | 261,235 | 247.20 | 246.75 | 3.82 | 3.81 | 2.50 | 2.50 | 1.3700 | 1.37 | -55.45%
| 7.52% | 30-Jun-2020 | 2.22 | 0.90 | 58.12 | 1.62 | 1.72% | 1.13% | 19-Aug-2020 | 4.42 | 1.79 | 115.71 | 3.23 | 0.86% | 0.57% |
| 31-Dec-2020 | 19-May-2020 | 31-Mar-2020 | 1 | 819,921 | 30,880 | 22,415 | 22,399 | 15,673 | 350,047 | 69.98% | 2.73% | 6.40% | 261,229 | 313.87 | 313.30 | 8.57 | 8.56 | 6.00 | 5.99 | 1.3400 | 1.34 | 112.54%
| 14.18% | 31-Mar-2020 | 1.26 | 0.40 | 14.69 | 0.94 | 6.81% | 4.76% | 19-May-2020 | 1.88 | 0.60 | 21.93 | 1.40 | 4.56% | 3.19% |
| 31-Dec-2019 | 20-Feb-2020 | 31-Dec-2019 | 4 | 715,683 | -238,474 | -178,733 | -178,598 | - | 336,573 | - % | -24.97% | -53.06% | 260,910 | 274.30 | 273.47 | -68.45 | -68.24 | 0.00 | 0.00 | 1.2900 | 1.29 | -37,230.56%
| -4,125.20% | 31-Dec-2019 | 2.06 | 0.75 | -3.01 | 1.60 | -33.23% | 0.00% | 20-Feb-2020 | 2.04 | 0.74 | -2.98 | 1.58 | -33.55% | 0.00% |
| 31-Dec-2019 | 20-Nov-2019 | 30-Sep-2019 | 3 | 716,849 | 3,885 | 376 | 481 | - | 516,387 | - % | 0.05% | 0.09% | 260,802 | 274.86 | 273.91 | 0.18 | 0.18 | 0.00 | 0.00 | 1.9800 | 1.97 | -94.82%
| -96.80% | 30-Sep-2019 | 2.44 | 0.89 | 1,322.99 | 1.23 | 0.08% | 0.00% | 20-Nov-2019 | 2.21 | 0.80 | 1,198.28 | 1.12 | 0.08% | 0.00% |
| 31-Dec-2019 | 23-Aug-2019 | 30-Jun-2019 | 2 | 601,890 | 12,481 | 9,262 | 9,281 | 6,514 | 518,564 | 70.19% | 1.54% | 1.79% | 260,585 | 230.98 | 229.99 | 3.56 | 3.55 | 2.50 | 2.49 | 1.9900 | 1.98 | -52.69%
| 72.06% | 28-Jun-2019 | 2.84 | 1.23 | 79.74 | 1.43 | 1.25% | 0.88% | 23-Aug-2019 | 2.66 | 1.15 | 74.69 | 1.34 | 1.34% | 0.94% |
| 31-Dec-2019 | 16-May-2019 | 31-Mar-2019 | 1 | 786,108 | 30,243 | 19,648 | 19,617 | 15,630 | 528,825 | 79.68% | 2.50% | 3.71% | 260,505 | 301.76 | 300.38 | 7.53 | 7.50 | 6.00 | 5.97 | 2.0300 | 2.02 | 342.12%
| 11.55% | 29-Mar-2019 | 2.27 | 0.75 | 30.14 | 1.12 | 3.32% | 2.64% | 16-May-2019 | 2.36 | 0.78 | 31.34 | 1.16 | 3.19% | 2.54% |
| 31-Dec-2018 | 21-Feb-2019 | 31-Dec-2018 | 4 | 596,644 | 11,940 | 4,570 | 4,437 | 5,202 | 509,862 | 117.26% | 0.77% | 0.87% | 260,134 | 229.36 | 227.98 | 1.71 | 1.70 | 2.00 | 1.99 | 1.9600 | 1.95 | -70.52%
| -79.55% | 31-Dec-2018 | 2.78 | 1.21 | 162.99 | 1.42 | 0.61% | 0.72% | 21-Feb-2019 | 2.76 | 1.20 | 161.81 | 1.41 | 0.62% | 0.72% |
| 31-Dec-2018 | 19-Nov-2018 | 30-Sep-2018 | 3 | 587,660 | 17,603 | 15,305 | 15,051 | 13,000 | 522,618 | 86.38% | 2.60% | 2.88% | 260,009 | 226.02 | 224.55 | 5.79 | 5.75 | 5.00 | 4.97 | 2.0100 | 2.00 | 179.03%
| 320.42% | 28-Sep-2018 | 2.89 | 1.28 | 49.93 | 1.44 | 2.00% | 1.73% | 19-Nov-2018 | 3.09 | 1.37 | 53.38 | 1.54 | 1.87% | 1.62% |
| 31-Dec-2018 | 17-Aug-2018 | 30-Jun-2018 | 2 | 582,729 | 11,970 | 5,766 | 5,394 | 10,392 | 519,642 | 192.67% | 0.99% | 1.04% | 259,821 | 224.28 | 222.67 | 2.08 | 2.06 | 4.00 | 3.97 | 2.0000 | 1.99 | -69.33%
| -43.34% | 29-Jun-2018 | 2.88 | 1.28 | 138.73 | 1.44 | 0.72% | 1.39% | 17-Aug-2018 | 3.11 | 1.39 | 149.80 | 1.56 | 0.67% | 1.29% |
| 31-Dec-2018 | 16-May-2018 | 31-Mar-2018 | 1 | 617,923 | 28,707 | 17,589 | 17,586 | 12,991 | 524,838 | 73.87% | 2.85% | 3.35% | 259,821 | 237.83 | 236.11 | 6.77 | 6.72 | 5.00 | 4.96 | 2.0200 | 2.01 | -18.96%
| -7.07% | 30-Mar-2018 | 4.28 | 1.80 | 63.23 | 2.12 | 1.58% | 1.17% | 16-May-2018 | 4.07 | 1.71 | 60.13 | 2.01 | 1.66% | 1.23% |
| 31-Dec-2017 | 27-Feb-2018 | 31-Dec-2017 | 4 | 613,196 | 19,866 | 22,088 | 21,700 | 15,573 | 526,888 | 71.77% | 3.60% | 4.12% | 259,551 | 236.25 | 234.31 | 8.36 | 8.29 | 6.00 | 5.95 | 2.0300 | 2.01 | 506.15%
| 2,695.69% | 29-Dec-2017 | 4.60 | 1.95 | 55.02 | 2.27 | 1.82% | 1.30% | 27-Feb-2018 | 4.04 | 1.71 | 48.32 | 1.99 | 2.07% | 1.49% |
| 31-Dec-2017 | 15-Nov-2017 | 30-Sep-2017 | 3 | 574,503 | 15,271 | 3,890 | 3,580 | 12,973 | 531,892 | 362.37% | 0.68% | 0.67% | 259,460 | 221.42 | 219.52 | 1.38 | 1.37 | 5.00 | 4.96 | 2.0500 | 2.03 | -62.39%
| -72.59% | 29-Sep-2017 | 4.14 | 1.87 | 300.05 | 2.02 | 0.33% | 1.21% | 15-Nov-2017 | 3.82 | 1.73 | 276.85 | 1.86 | 0.36% | 1.31% |
| 31-Dec-2017 | 16-Aug-2017 | 30-Jun-2017 | 2 | 517,967 | 10,150 | 9,751 | 9,520 | 10,376 | 542,147 | 108.99% | 1.88% | 1.76% | 259,400 | 199.68 | 197.92 | 3.67 | 3.64 | 4.00 | 3.96 | 2.0900 | 2.07 | -49.69%
| -36.51% | 30-Jun-2017 | 4.58 | 2.29 | 124.80 | 2.19 | 0.80% | 0.87% | 16-Aug-2017 | 4.19 | 2.10 | 114.17 | 2.00 | 0.88% | 0.95% |
| 31-Dec-2017 | 16-May-2017 | 31-Mar-2017 | 1 | 618,294 | 27,777 | 19,258 | 18,923 | 10,368 | 544,360 | 54.79% | 3.11% | 3.48% | 259,219 | 238.52 | 236.26 | 7.30 | 7.23 | 4.00 | 3.96 | 2.1000 | 2.08 | 2,363.52%
| 2.96% | 31-Mar-2017 | 4.89 | 2.05 | 66.99 | 2.33 | 1.49% | 0.82% | 16-May-2017 | 4.72 | 1.98 | 64.66 | 2.25 | 1.55% | 0.85% |
| 31-Dec-2016 | 21-Feb-2017 | 31-Dec-2016 | 4 | 582,816 | 4,069 | -900 | -836 | 7,773 | 531,169 | - % | -0.15% | -0.16% | 259,107 | 224.93 | 222.70 | -0.32 | -0.32 | 3.00 | 2.97 | 2.0500 | 2.03 | -106.40%
| -105.20% | 30-Dec-2016 | 5.30 | 2.36 | -1,642.66 | 2.59 | -0.06% | 0.57% | 21-Feb-2017 | 5.12 | 2.28 | -1,586.88 | 2.50 | -0.06% | 0.59% |
| 31-Dec-2016 | 21-Nov-2016 | 30-Sep-2016 | 3 | 515,215 | 19,923 | 12,648 | 13,061 | 10,365 | 531,250 | 79.37% | 2.45% | 2.46% | 259,146 | 198.81 | 196.87 | 5.04 | 4.99 | 4.00 | 3.96 | 2.0500 | 2.03 | -12.90%
| -34.60% | 30-Sep-2016 | 5.58 | 2.81 | 110.71 | 2.72 | 0.90% | 0.72% | 21-Nov-2016 | 5.70 | 2.87 | 113.10 | 2.78 | 0.88% | 0.70% |
| 31-Dec-2016 | 19-Aug-2016 | 30-Jun-2016 | 2 | 531,796 | 21,487 | 15,641 | 14,995 | 12,949 | 524,177 | 86.36% | 2.94% | 2.86% | 258,981 | 205.34 | 203.20 | 5.79 | 5.73 | 5.00 | 4.95 | 2.0240 | 2.00 | -18.41%
| -7.54% | 30-Jun-2016 | 5.50 | 2.68 | 94.99 | 2.72 | 1.05% | 0.91% | 19-Aug-2016 | 5.62 | 2.74 | 97.06 | 2.78 | 1.03% | 0.89% |
| 31-Dec-2016 | 13-May-2016 | 31-Mar-2016 | 1 | 559,195 | 26,538 | 18,470 | 18,379 | 10,354 | 515,906 | 56.34% | 3.30% | 3.56% | 258,859 | 216.02 | 213.67 | 7.10 | 7.02 | 4.00 | 3.96 | 1.9930 | 1.97 | 14.43%
| -42.19% | 31-Mar-2016 | 5.76 | 2.67 | 81.13 | 2.89 | 1.23% | 0.69% | 13-May-2016 | 5.60 | 2.59 | 78.87 | 2.81 | 1.27% | 0.71% |
| 31-Dec-2015 | 15-Feb-2016 | 31-Dec-2015 | 4 | 680,150 | 23,717 | 16,041 | 16,062 | 18,134 | 529,786 | 112.90% | 2.36% | 3.03% | 259,064 | 262.54 | 259.89 | 6.20 | 6.14 | 7.00 | 6.93 | 2.0450 | 2.02 | -19.57%
| -56.23% | 31-Dec-2015 | 6.36 | 2.42 | 102.58 | 3.11 | 0.97% | 1.10% | 15-Feb-2016 | 6.19 | 2.36 | 99.84 | 3.03 | 1.00% | 1.13% |
| 31-Dec-2015 | 26-Nov-2015 | 30-Sep-2015 | 3 | 524,413 | 25,337 | 19,975 | 19,971 | 23,312 | 534,373 | 116.73% | 3.81% | 3.74% | 259,027 | 202.45 | 200.38 | 7.71 | 7.63 | 9.00 | 8.91 | 2.0630 | 2.04 | 23.15%
| 33.54% | 30-Sep-2015 | 6.50 | 3.21 | 84.31 | 3.15 | 1.19% | 1.38% | 26-Nov-2015 | 6.50 | 3.21 | 84.31 | 3.15 | 1.19% | 1.38% |
| 31-Dec-2015 | 17-Aug-2015 | 30-Jun-2015 | 2 | 512,845 | 25,056 | 16,642 | 16,217 | 18,134 | 528,477 | 111.82% | 3.25% | 3.07% | 259,057 | 197.97 | 195.96 | 6.26 | 6.20 | 7.00 | 6.93 | 2.0400 | 2.02 | -48.99%
| 1.51% | 30-Jun-2015 | 7.13 | 3.60 | 113.90 | 3.50 | 0.88% | 0.98% | 17-Aug-2015 | 5.65 | 2.85 | 90.26 | 2.77 | 1.11% | 1.24% |
| 31-Dec-2015 | 18-May-2015 | 31-Mar-2015 | 1 | 471,904 | 38,612 | 31,926 | 31,794 | 18,123 | 528,173 | 57.00% | 6.77% | 6.02% | 258,908 | 182.27 | 180.32 | 12.28 | 12.15 | 7.00 | 6.93 | 2.0400 | 2.02 | -13.36%
| 21.27% | 31-Mar-2015 | 6.00 | 3.29 | 48.86 | 2.94 | 2.05% | 1.17% | 18-May-2015 | 6.91 | 3.79 | 56.27 | 3.39 | 1.78% | 1.01% |
| 31-Dec-2014 | 23-Feb-2015 | 31-Dec-2014 | 4 | 627,103 | 37,854 | 36,621 | 36,697 | 31,055 | 525,351 | 84.63% | 5.84% | 6.99% | 258,794 | 242.32 | 239.62 | 14.18 | 14.02 | 12.00 | 11.87 | 2.0300 | 2.01 | 145.38%
| 76.32% | 31-Dec-2014 | 4.58 | 1.89 | 32.30 | 2.26 | 3.10% | 2.62% | 23-Feb-2015 | 5.28 | 2.18 | 37.24 | 2.60 | 2.69% | 2.27% |
| 31-Dec-2014 | 21-Nov-2014 | 30-Sep-2014 | 3 | 502,086 | 24,945 | 15,001 | 14,955 | 20,698 | 507,124 | 138.41% | 2.99% | 2.95% | 258,737 | 194.05 | 191.85 | 5.78 | 5.71 | 8.00 | 7.91 | 1.9600 | 1.94 | -6.38%
| 298.69% | 30-Sep-2014 | 4.63 | 2.39 | 80.10 | 2.36 | 1.25% | 1.73% | 21-Nov-2014 | 4.45 | 2.29 | 76.99 | 2.27 | 1.30% | 1.80% |
| 31-Dec-2014 | 21-Aug-2014 | 30-Jun-2014 | 2 | 525,072 | 24,622 | 15,957 | 15,975 | 10,356 | 502,293 | 64.83% | 3.04% | 3.18% | 258,914 | 202.80 | 200.63 | 6.17 | 6.10 | 4.00 | 3.96 | 1.9400 | 1.92 | -39.07%
| 172.38% | 30-Jun-2014 | 4.61 | 2.27 | 74.72 | 2.38 | 1.34% | 0.87% | 21-Aug-2014 | 4.62 | 2.28 | 74.88 | 2.38 | 1.34% | 0.87% |
| 31-Dec-2014 | 14-May-2014 | 31-Mar-2014 | 1 | 468,672 | 38,159 | 26,646 | 26,217 | 10,352 | 515,022 | 39.49% | 5.69% | 5.09% | 258,805 | 181.09 | 179.08 | 10.13 | 10.02 | 4.00 | 3.96 | 1.9900 | 1.97 | 25.96%
| 5.84% | 31-Mar-2014 | 4.46 | 2.46 | 44.03 | 2.24 | 2.27% | 0.90% | 14-May-2014 | 4.70 | 2.60 | 46.40 | 2.36 | 2.16% | 0.85% |
| 31-Dec-2013 | 24-Feb-2014 | 31-Dec-2013 | 4 | 567,860 | 33,007 | 21,267 | 20,813 | 16,049 | 486,672 | 77.11% | 3.75% | 4.28% | 258,868 | 219.36 | 216.98 | 8.04 | 7.95 | 6.20 | 6.13 | 1.8800 | 1.86 | 454.87%
| 362.33% | 31-Dec-2013 | 4.45 | 2.03 | 55.35 | 2.37 | 1.81% | 1.39% | 24-Feb-2014 | 4.29 | 1.96 | 53.36 | 2.28 | 1.87% | 1.45% |
| 31-Dec-2013 | 19-Nov-2013 | 30-Sep-2013 | 3 | 440,807 | 13,461 | 4,170 | 3,751 | 7,760 | 473,402 | 206.90% | 0.95% | 0.79% | 258,689 | 170.40 | 168.44 | 1.45 | 1.43 | 3.00 | 2.97 | 1.8300 | 1.81 | -36.04%
| -85.14% | 30-Sep-2013 | 4.82 | 2.83 | 332.41 | 2.63 | 0.30% | 0.62% | 19-Nov-2013 | 4.72 | 2.77 | 325.52 | 2.58 | 0.31% | 0.64% |
| 31-Dec-2013 | 16-Aug-2013 | 30-Jun-2013 | 2 | 437,633 | 9,605 | 6,171 | 5,865 | 8,810 | 480,568 | 150.22% | 1.41% | 1.22% | 258,370 | 169.38 | 167.22 | 2.27 | 2.24 | 3.41 | 3.37 | 1.8600 | 1.84 | -76.32%
| -62.67% | 28-Jun-2013 | 4.49 | 2.65 | 197.80 | 2.41 | 0.51% | 0.76% | 16-Aug-2013 | 4.66 | 2.75 | 205.29 | 2.51 | 0.49% | 0.73% |
| 31-Dec-2013 | 15-May-2013 | 31-Mar-2013 | 1 | 500,339 | 36,924 | 25,153 | 24,771 | 8,825 | 484,829 | 35.63% | 5.03% | 5.11% | 117,676 | 425.18 | 191.18 | 21.05 | 9.47 | 7.50 | 3.37 | 4.1200 | 1.85 | 412.21%
| -13.64% | 29-Mar-2013 | 8.26 | 1.94 | 39.24 | 2.00 | 2.55% | 0.91% | 15-May-2013 | 9.26 | 2.18 | 43.99 | 2.25 | 2.27% | 0.81% |
| 31-Dec-2012 | 18-Feb-2013 | 31-Dec-2012 | 4 | 482,404 | 4,248 | -7,468 | -7,934 | 11,771 | 472,037 | - % | -1.55% | -1.68% | 117,715 | 409.81 | 184.33 | -6.74 | -3.03 | 10.00 | 4.50 | 4.0100 | 1.80 | -131.43%
| -166.44% | 31-Dec-2012 | 8.10 | 1.98 | -120.18 | 2.02 | -0.83% | 1.23% | 18-Feb-2013 | 7.80 | 1.90 | -115.73 | 1.95 | -0.86% | 1.28% |
| 31-Dec-2012 | 06-Nov-2012 | 30-Sep-2012 | 3 | 426,460 | 28,493 | 25,536 | 25,247 | 11,764 | 496,469 | 46.60% | 5.99% | 5.09% | 117,646 | 362.49 | 162.95 | 21.46 | 9.65 | 10.00 | 4.50 | 4.2200 | 1.90 | 60.68%
| 133.53% | 28-Sep-2012 | 7.55 | 2.08 | 35.18 | 1.79 | 2.84% | 1.32% | 06-Nov-2012 | 8.25 | 2.28 | 38.44 | 1.95 | 2.60% | 1.21% |
| 31-Dec-2012 | 08-Aug-2012 | 30-Jun-2012 | 2 | 456,737 | 27,618 | 16,077 | 15,713 | 8,827 | 481,394 | 56.18% | 3.52% | 3.26% | 117,700 | 388.05 | 174.52 | 13.35 | 6.00 | 7.50 | 3.37 | 4.0900 | 1.84 | -45.22%
| 12.88% | 29-Jun-2012 | 10.18 | 2.62 | 76.25 | 2.49 | 1.31% | 0.74% | 08-Aug-2012 | 8.83 | 2.28 | 66.14 | 2.16 | 1.51% | 0.85% |
| 31-Dec-2012 | 03-May-2012 | 31-Mar-2012 | 1 | 446,745 | 42,955 | 29,061 | 28,685 | 8,824 | 474,161 | 30.76% | 6.51% | 6.05% | 117,657 | 379.70 | 170.71 | 24.38 | 10.96 | 7.50 | 3.37 | 4.0300 | 1.81 | 140.20%
| 85.26% | 30-Mar-2012 | 5.90 | 1.55 | 24.20 | 1.46 | 4.13% | 1.27% | 03-May-2012 | 5.90 | 1.55 | 24.20 | 1.46 | 4.13% | 1.27% |
| 31-Dec-2011 | 22-Feb-2012 | 31-Dec-2011 | 4 | 367,786 | 16,368 | 12,182 | 11,942 | 35,296 | 514,153 | 295.57% | 3.31% | 2.32% | 117,655 | 312.60 | 140.53 | 10.15 | 4.56 | 30.00 | 13.49 | 4.3700 | 1.96 | 10.46%
| 629.34% | 30-Dec-2011 | 5.36 | 1.71 | 52.81 | 1.23 | 1.89% | 5.60% | 22-Feb-2012 | 5.90 | 1.89 | 58.13 | 1.35 | 1.72% | 5.08% |
| 31-Dec-2011 | 01-Nov-2011 | 30-Sep-2011 | 3 | 371,432 | 15,646 | 10,959 | 10,811 | - | 464,092 | - % | 2.95% | 2.33% | 106,933 | 347.35 | 141.93 | 10.11 | 4.13 | 0.00 | 0.00 | 4.3400 | 1.77 | -22.33%
| 25.91% | 30-Sep-2011 | 5.90 | 1.70 | 58.36 | 1.36 | 1.71% | 0.00% | 01-Nov-2011 | 5.90 | 1.70 | 58.36 | 1.36 | 1.71% | 0.00% |
| 31-Dec-2011 | 10-Aug-2011 | 30-Jun-2011 | 2 | 396,435 | 19,380 | 14,045 | 13,920 | - | 451,517 | - % | 3.54% | 3.08% | 106,994 | 370.52 | 151.48 | 13.01 | 5.32 | 0.00 | 0.00 | 4.2200 | 1.73 | -10.10%
| -5.61% | 30-Jun-2011 | 5.90 | 1.59 | 45.35 | 1.40 | 2.21% | 0.00% | 10-Aug-2011 | 5.90 | 1.59 | 45.35 | 1.40 | 2.21% | 0.00% |
| 31-Dec-2011 | 13-May-2011 | 31-Mar-2011 | 1 | 385,328 | 21,792 | 15,599 | 15,484 | - | 437,661 | - % | 4.05% | 3.54% | 107,007 | 360.09 | 147.24 | 14.47 | 5.92 | 0.00 | 0.00 | 4.0900 | 1.67 | 786.35%
| 66.37% | 31-Mar-2011 | 5.73 | 1.59 | 39.60 | 1.40 | 2.53% | 0.00% | 13-May-2011 | 5.05 | 1.40 | 34.90 | 1.23 | 2.87% | 0.00% |
| 31-Dec-2010 | 25-Feb-2011 | 31-Dec-2010 | 4 | 376,116 | -2,701 | -1,952 | -2,256 | - | 421,262 | - % | -0.52% | -0.54% | 106,919 | 351.78 | 143.72 | -2.11 | -0.86 | 0.00 | 0.00 | 3.9400 | 1.61 | -126.28%
| -110.29% | 30-Dec-2010 | 5.31 | 1.51 | -251.66 | 1.35 | -0.40% | 0.00% | 25-Feb-2011 | 5.35 | 1.52 | -253.55 | 1.36 | -0.39% | 0.00% |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
| Trade this stock for as low as 0.05% brokerage. Find out more. |
 MZM2511 and has an overall efficacy of 50.4 percent in Brazil's final-stage trials. 13/01/2021 1:35 PM MZM2511 1. China’s Sinovac COVID-19 Vaccine Less Effective than Initially Thought Source: https://www.voanews.com/covid-19-pandemic/chinas-sinovac-covid-19-vaccine-less-effective-initially-thought 2. Sinovac's Covid-19 vaccine 78% effective in late-stage trial in Brazil — source Source: https://www.theedgemarkets.com/article/sinovacs-covid19-vaccine-78-effective-latestage-trial-brazil-%E2%80%94-source 3. New Brazil data shows disappointing 50.4% efficacy for China's CoronaVac vaccine Source: https://www.theedgemarkets.com/article/new-brazil-data-shows-disappointing-504-efficacy-chinas-coronavac-vaccine 4. Coronavirus: Scientists concerned by way data from Chinese drug firm Sinovac’s vaccine trials is coming out Source: https://sg.news.yahoo.com/coronavirus-scientists-concerned-way-data-140100178.html 13/01/2021 1:37 PM Loading This vaccine is like add ons in video games, need to 'stack' to become stronger .. 1dose 50% + 1dose 50% = 100% no limit .. 13/01/2021 1:43 PM MZM2511 Better give 3 doses. 50% + 50% + 50% = 150% He He I personally don't want to have this type of vaccine..... 13/01/2021 1:46 PM BennyWhittman Bolih U-Turn lagi.... https://www.malaymail.com/news/malaysia/2021/01/13/khairy-malaysia-to-study-sinovac-clinical-trial-data-before-approving-covid/1940067 13/01/2021 5:34 PM MZM2511 Wariness in Indonesia as Chinese Sinovac COVID-19 jabs start. "I'm not rejecting vaccines, I'm rejecting Sinovac's," said Yusdeny Lanasakti, an East Java doctor who is worried about the vaccine's efficacy. Source: https://uk.news.yahoo.com/wariness-indonesia-chinese-sinovac-covid-080953468.html 13/01/2021 5:46 PM Financier Inix is venturing into the vaccine. This puts Inix in a position better than those of other glove manufacturers. https://www.bursamalaysia.com/market_information/announcements/company... 13/01/2021 5:51 PM emc2garylow 50% 20% or 5% only u still need to pay the price for 12 millions dose lor, 50 % u pay for 6 millions dose only mei.... Later u go buy burger and say abang ini burger tak sedap la, bayar separuh boleh bang? 13/01/2021 9:13 PM chuosyew https://www.enanyang.my/%E5%BE%B7%E5%9B%BD%E4%B9%8B%E5%A3%B0/%E5%B7%B4%E8%A5%BF%E5%86%8D%E8%B0%83%E9%99%8D%E7%A7%91%E5%85%B4%E7%96%AB%E8%8B%97%E4%BF%9D%E6%8A%A4%E5%8A%9B-%E4%B8%AD%E5%AE%98%E5%AA%92%E6%80%A5%E2%80%9C%E6%8A%A4%E8%88%AA%E2%80%9D 13/01/2021 9:46 PM chuosyew please read, only found mandarin. sinovac vaccine ia safe. the trial at brasil is use for frontliner. 13/01/2021 9:48 PM TecStock https://news.cgtn.com/news/2021-01-13/China-s-COVID-19-vaccine-may-be-new-candidate-in-EU-Italy-X1umZpDoTm/index.html 13/01/2021 10:17 PM chuosyew https://news.cgtn.com/news/2021-01-13/CEO-Sinovac-COVID-19-vaccine-safe-and-efficient-X1ac7YSHcY/share_amp.html 13/01/2021 10:53 PM  kancil850 My friend in jakarta told me today sinovac jab is starting to be administered over in his city, but he is not part of as he is older, over 60 yo. 13/01/2021 10:58 PM BennyWhittman Water is safe, try water and it's cheap. Safe doesn't mean it's EFFECTIVE. Damn it, people's lives at stake and they still want to profit on fake meds. The term safe means it doesn't have adverse side effect. The main criteria is to PROTECT and do it's job well, with efficacy above 90% Those who want to have FALSE PROTECTION, please line up for this shot. 14/01/2021 8:28 AM Goldberg Read this article: Evidence that prove JP Morgan's Jeffrey Ng analyst report on Glove is irresponsible and materially full with false data https://klse.i3investor.com/blogs/GillianTan/2021-01-14-story-h1539323... 14/01/2021 8:42 AM BennyWhittman Anyone who believed the tales told by Investment Bankers duly DESERVED what they get. Suffer the consequences. JP also predicted TG to go down by 50% to RM3.50. Hogwash. 14/01/2021 1:07 PM TecStock https://newsaf.cgtn.com/news/2021-01-14/Turkish-health-minister-gets-Sinovac-vaccine-jab-X1RW4FaqhW/index.html 14/01/2021 1:36 PM chuosyew https://www.astroawani.com/berita-dunia/turkey-approves-chinabased-sinovac-vaccines-emergency-use-277713 14/01/2021 3:17 PM eyeHunter We refer to Pharma’s announcement dated 12 January 2021 in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release: 1) Whether PLS possesses the required expertise, knowhow and resources to manufacture the Covid-19 vaccine. 2) The tentative timeframe to enter into the Local Manufacturing Agreement and a Technology and Know-How License Agreement with SINOVAC LS. 3) The risks in relation to the manufacturing of the Covid-19 vaccine that PLS may be exposed to. 4) To elaborate the manner in which PLS intends to market and distribute the Covid-19 vaccine and whether any contract has been secured todate. 5) To specify the relevant authorities’ approvals required for the clinical trial of the Covid-19 vaccine and the manufacturing, distribution and sale of the Covid-19 vaccine in Malaysia together with the status of approval, where applicable. 6) The estimated total capital outlay or costs to be incurred and the source of funding for the manufacturing of Covid- 19 vaccine. Please furnish Bursa Securities with your reply within one (1) market day from the date hereof. Yours faithfully Listing Regulation 14/01/2021 6:44 PM BennyWhittman Mr President aka Joyvest (paid trooper from Bintai and Solution forum), We didn't know that Pfizer-BioNTech Pharmceutical belongs to your father. If so, kindly expedite Malaysian' procurement. KJ has announced that MOSTI is flexible and will not proceed if any Vaccines failed it's Standard and Efficiency. NPRA also have the CTIL certified prior to any APPROVALS. 14/01/2021 7:49 PM shark3011 https://www.freemalaysiatoday.com/category/nation/2021/01/14/rm5mil-fine-and-jail-if-private-hospitals-say-no-to-covid-19-patients/ 14/01/2021 9:40 PM Godofgambler Wow pharma going to manufacture sinovac vaccine locally? Well done!!! 14/01/2021 11:39 PM Godofgambler Pharmaniaga said it had initiated negotiation for the local manufacturing agreement as well as the technology and know-how licence agreement with Sinovac LS, which are expected to be executed within one month 14/01/2021 11:47 PM cloudde I'm not sure if they're going to manufacture the vaccines but from the announcement, they managed to procure ready vaccines to be used and in bulk (for the fill and finish). Bear in mind that we're in a pandemic and that many high economic activities are under MCO. My guess is that the bulk of vaccines they've procured will also be allocated and prioritized to KKM and private hospitals. Don't see this as a race between Pharma and Duopharma as even with PFE's and Sinovac's vaccines secured, we're still short to cover the target 80% population. And each person will require 2 doses. Profitability wise, this is a good additional mid-term revenue source for PHARMA and I don't see it going away anytime soon. Even with other vaccines supply, the fill and finish approach is still the most practical to reduce overall vaccines cost to users. I highly doubt PFE or others would allow manufacturing locally and not sure if it's feasible to transport huge bulk of PFE for fill and finish (imagine to ensure huge tanks at -80 degrees - such technological challenge) I'm not privy to Duopharma's progress in securing vaccine supplies besides this old post. Anyone has updated information? It's kinda odd since KJ was seen as leading the negotiations for both companies but only announced for PHARMA. Did Duopharma's negotiation fell apart? https://www.theedgemarkets.com/article/duopharma-ready-package-covid19-vaccines 15/01/2021 12:19 PM BennyWhittman MOSTI have come out in defense of their choice in Sinovac's CoronaVac. As the reports of lower than earlier expected efficacy, perhaps they may have a second look. Otherwise, NPRA might need to properly scrutinise the CTIL from other countries, especially Brazil and now Indonesia. As for R&D and transfer of technology with local manufacturing, that would be a step too soon at the moment but still on the cards. Pfizer's vaccine requirement for the cold chain transportation has been addressed by MOSTI with the recent purchase of some 55 units of deep freeze fridges. The vaccines would be most probably shipped in vials and require dilution in saline before shooting into arms. Should not be thawed for FnF. The genetic engineering technology for this vaccine may still not be transferable give the high end equipment, facilities and meticulous procedures. Nobody hold privy to the GLCs roles and responsibilities in rolling out the vaccines. We are all having calculated definitions of their capabilities and on-going current services rendered to MOH. Coupled with the fact that MOSTI had announced their participation in the roll-out plans. 15/01/2021 1:06 PM BennyWhittman The reason that Pharma is getting the chinese vaccine Contract is because they are the GLC which has been performing the logistic and deliveries to all Govt hospitals, penetrating even the rural jungle villages. As mentioned before, NO MIDDLEMAN. Some naysayers still don't seem to understand the context of commerce in business transactions. Govt is buying the vaccine and bringing in Pharma to the table. It's not that Pharma has decided to buying the vaccine and sell it to the govt. The govt approved the procurement and hand it to Pharma to facilitate the real and actual import and downstream exercise. The same scenario would presumably be happening to Dpharma. With Pharma's re-purposing their FnF facility and hitting full capacities, Dpharma may be awarded the AZ or Sputnik V, although AZ seems higher possibility with their approved EUA status from UK, USA, Europe and many other countries. 15/01/2021 1:17 PM flyborn Good explanation benny Same principle of business happen in uae, whereby government purchases such vaccines and government agencies distribute to the uae people including ex. Hopefully Pharmaniaga will get profits for that. 15/01/2021 7:12 PM TecStock https://www.euroweeklynews.com/2021/01/15/norway-changes-vaccine-guidelines-after-23-deaths/ 16/01/2021 3:23 PM eYuppie Will govt continue with Sinovac after reported only 50.3% efficacy in Brazil? How about the Chinese vaccine Sinopharm? Cambodia PM is injecting the Sinopharm vaccine. https://www.khmertimeskh.com/50804325/pm-i-will-get-the-covid-19-vaccine-first/ 17/01/2021 7:31 PM  FortuneBlooming Something fishy: Pfizer CEO not jabbing himself with Pfizer vaccine raises big questions https://www.news18.com/amp/news/buzz/something-fishy-pfizer-ceo-not-getting-his-own-companys-covid-19-vaccine-raises-questions-3182408.html 17/01/2021 10:34 PM Godofgambler https://www.google.com/amp/s/news.cgtn.com/news/2021-01-17/China-s-vaccine-can-cross-neutralize-different-COVID-strains-CNBG-X7DidHHXP2/share_amp.html 17/01/2021 10:57 PM bigby7 China Vaccine 50% effective.. Now pfizer deaths..From 23 to 29 now Scary oh.. Tomorrow market merah.. https://www.bloomberg.com/news/articles/2021-01-16/norway-vaccine-fata... 18/01/2021 12:12 AM eYuppie https://www.scmp.com/coronavirus/europe/article/3118087/coronavirus-norway-raises-concern-over-pfizer-jabs-elderly Norway has expressed increasing concern about the safety of the Pfizer-BioNTech vaccine on elderly people with serious underlying health conditions after raising an estimate of the "number who died after receiving inoculations to 29". 18/01/2021 12:42 AM Godofgambler https://www.reuters.com/article/us-health-coronavirus-brazil/brazil-clears-emergency-use-of-sinovac-astrazeneca-vaccines-shots-begin-idUSKBN29M0M3 18/01/2021 7:31 AM eYuppie https://www.khmertimeskh.com/50804460/why-were-us-media-silent-on-pfizer-vaccine-deaths/ Why were US media silent on Pfizer vaccine deaths? 18/01/2021 12:42 PM  |
|